Evidence map›Paper›PMID 34354671›Full record

ReviewFrontiers in endocrinology2021

Clinical Unmet Needs in the Treatment of Adrenal Crisis: Importance of the Patient's Perspective.

Kim M J A Claessen, Cornelie D Andela, Nienke R Biermasz, Alberto M Pereira

Open access · goldAbstract readReview
In one paragraph

Review in Frontiers in endocrinology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
2.1field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 20 citations in OpenAlex.

  1. Trial
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Observational
  8. Osteoporosis in Adrenal Insufficiency: Could Metformin be Protective?Indian journal of clinical biochemistry : IJCB · 2025
    Review
  9. Article
  10. Article
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Kim M J A ClaessenDepartment of Medicine, Division of Endocrinology, and Center for Endocrine Tumors Leiden (CETL), and European Reference Network on Rare Endocrine Conditions (Endo-ERN), Leiden University Medical Center, Leiden, Netherlands.
Cornelie D AndelaDepartment of Medicine, Division of Endocrinology, and Center for Endocrine Tumors Leiden (CETL), and European Reference Network on Rare Endocrine Conditions (Endo-ERN), Leiden University Medical Center, Leiden, Netherlands.
Nienke R BiermaszDepartment of Medicine, Division of Endocrinology, and Center for Endocrine Tumors Leiden (CETL), and European Reference Network on Rare Endocrine Conditions (Endo-ERN), Leiden University Medical Center, Leiden, Netherlands.
Alberto M PereiraDepartment of Medicine, Division of Endocrinology, and Center for Endocrine Tumors Leiden (CETL), and European Reference Network on Rare Endocrine Conditions (Endo-ERN), Leiden University Medical Center, Leiden, Netherlands.
Leiden University Medical Center · NLERN GUARD-Heart · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Adrenal crisis is the most severe manifestation of adrenal insufficiency (AI), but AI can present with variable signs and symptoms of gradual severity. Despite current hormone replacement strategies, adrenal crisis is still one of the leading causes of mortality in AI patients. Although underlying factors explaining differences in interindividual susceptibility are not completely understood, several subgroups are particularly vulnerable to adrenal crises, such as patients with primary AI, and patients treated for Cushing's syndrome. Currently, the health care professional faces several challenges in the care for AI patients, including the lack of reliable biomarkers measuring tissue cortisol concentrations, absence of a universally used definition for adrenal crisis, and lack of clinical tools to identify individual patients at increased risk. Also from the patient's perspective, there are a number of steps to be taken in order to increase and evaluate self-management skills and, finally, improve health-related quality of life (HR-QoL). In this respect, the fact that inadequate handling of AI patients during stressful situations is a direct consequence of not remembering how to act due to severe weakness and cognitive dysfunction in the context of the adrenal crisis is quite underexposed. In this narrative review, we give an overview of different clinical aspects of adrenal crisis, and discuss challenges and unmet needs in the management of AI and the adrenal crisis from both the doctor's and patient's perspective. For the latter, we use original focus group data. Integration of doctor's and patient's perspectives is key for successful improvement of HR-QoL in patients with AI.

Indexed as

Quality of LifeAdrenal InsufficiencyHormone Replacement TherapyHumansNeeds Assessmentadrenal crisisadrenal insufficiencycortisolhydrocortisone replacementmortalitypatient’s perspectivequality of lifeunmet needs

Identifiers

PMID34354671
PMCPMC8329717
OpenAlexW3183848314

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.